Valentin Petrov

Mr. Valentin Petrov


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2025 in Molecules
Verified
Journal Article
Open access
PDF file
VPValentin Petrov
Valentin Petrov
TATeodora Aleksandrova
Teodora Aleksandrova
APAleksandar Pashev
Aleksandar Pashev
Dipeptidyl peptidase IV (DPP-IV) is a serine protease whose inhibition has been an object of considerable interest in the context of developing novel treatments for type 2 diabetes mellitus. The development of novel DPP-IV inhibitors from natural or synthetic origin has seen a growing scientific interest in recent years, especially during the SARS-CoV-2 pandemic, when DPP-IV inhibitors were found to be of beneficial therapeutic value for COVID-19 patients. The present manuscript aims to summarize the most recent information on the synthesis of different DPP-IV inhibitors, emphasizing the various heterocyclic scaffolds that can be found in them. Special attention is devoted to DPP-IV inhibitors that are currently in clinical trials. Different synthetic approaches for the construction of DPP-IV inhibitors are discussed, as well as the most recent developments in the field.

Verified
Journal Article
Open access
PDF file
APAleksandar Pashev
Aleksandar Pashev
VPValentin Petrov
Valentin Petrov
APAleksandrina Pesheva
Aleksandrina Pesheva
LPLidiya Petrova
Lidiya Petrova
KIKalina Ilieva
Kalina Ilieva
TATeodora Aleksandrova
Teodora Aleksandrova
Recent studies have discovered that aryl-substituted pyrido[2,1-a]isoquinolines have the potential to be highly active DPP IV inhibitors. In previous studies, we reported a novel synthetic approach for the construction of their sulfur-containing bioisosteric [1,4]thiazino[3,4-a]isoquinolines analogues, incorporating an additional aryl substituent. The present study aims to investigate the DPP IV inhibitory activity and cytotoxicity of the synthesized molecules by in vitro assay. The geometry optimization and molecular docking of the synthesized compounds were used to determine their binding modes to the active site of DPP IV. The docking analysis revealed that the energy-minimized poses of the studied compounds are close to the most important selectivity cliffs for DPP IV inhibition, forming hydrogen bonds and hydrophobic interactions with them. These results can be considered as a preliminary step towards further structural activity modifications.

21 January 2025 in Molbank
Verified
Journal Article
Open access
PDF file
VPValentin Petrov
Valentin Petrov
TATeodora Aleksandrova
Teodora Aleksandrova
APAleksandar Pashev
Aleksandar Pashev
The synthesis of the compound 9,10-dimethoxy-4-oxo-1-phenyl-1,3,4,6,7,11b-hexahydro-[1,4]thiazino[3,4-a]isoquinoline-1-carboxylic acid (4) was described for the first time using a reaction between 6,7-dimethoxy-3,4-dihydroisoquinoline and phenyl-substituted thiodiacetic anhydride 3. The reaction proceeded in excellent yield and furnished the compound 4 as a single diastereomer. The structure and relative configuration of 4 was elucidated using a combination of spectroscopic techniques–1H, 13C, COSY, HSQC, HMBC, and NOESY NMR spectra, as well as elemental analysis.